Fujian Medical University Union Hospital
🇨🇳China
Effects of Different Preoperative Oral Rehydration Protocols in Undergoing Thoracoscopic Radical Lung Cancer Surgery
Not yet recruiting
- Conditions
- Postoperative Delirium
- First Posted Date
- 2025-06-29
- Last Posted Date
- 2025-06-29
- Lead Sponsor
- Fujian Medical University Union Hospital
- Target Recruit Count
- 420
- Registration Number
- NCT07042503
Application of Targeted Axillary Lymph Node Resection in Axillary Surgery After Neoadjuvant Chemotherapy for Breast Cancer: an Open-label, Multicenter Study
Not Applicable
Active, not recruiting
- Conditions
- Breast Cancer SurgeryNeoadjuvant TherapySentinel Lymph Node Biopsy (SLNB)
- Interventions
- Drug: carbon suspension
- First Posted Date
- 2025-06-22
- Last Posted Date
- 2025-06-22
- Lead Sponsor
- Fujian Medical University Union Hospital
- Target Recruit Count
- 175
- Registration Number
- NCT07032220
- Locations
- 🇨🇳
Study Officials, Fuzhou, Fujian, China
Comparison of Cardiovascular Risks Between Hip Fracture Surgery With Continued DAPT（Dual Antiplatelet Therapy ） Within 6 Weeks vs After 6 Weeks Post-PCI（Percutaneous Coronary Intervention）: A Prospective Observational Cohort Study
Not yet recruiting
- Conditions
- PCI PatientsDAPT(Dual Antiplatelet Therapy)Hip Fracture Surgeries
- First Posted Date
- 2025-06-17
- Last Posted Date
- 2025-06-17
- Lead Sponsor
- Fujian Medical University Union Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT07024446
Tubeless Anesthesia in Preventing Lung Complications in Patients Undergoing Surgery for Early-Stage Lung Cancer
Not Applicable
Recruiting
- Conditions
- Lung Cancer Patients
- First Posted Date
- 2025-06-17
- Last Posted Date
- 2025-06-17
- Lead Sponsor
- Fujian Medical University Union Hospital
- Target Recruit Count
- 224
- Registration Number
- NCT07024433
- Locations
- 🇨🇳
Fujian Medical University Union Hospital, Fuzhou, Fujian, China
Chemotherapy-immunotherapy-based Split-course Adaptive Hypofractionated Radiotherapy for Extensive-stage SCLC
Phase 2
- Conditions
- Small-cell Lung Cancer
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-03-25
- Lead Sponsor
- Fujian Medical University Union Hospital
- Target Recruit Count
- 35
- Registration Number
- NCT06816966
- Locations
- 🇨🇳
Fujian Medical University Union Hospital,, Fuzhou, Fujian, China
A Prospective Multicenter Registry Study on BASIS Technique for Endovascular Therapy of Acute Large Vessel Occlusion Strokes Due to Intracranial Atherosclerotic Disease
Recruiting
- Conditions
- Acute Ischemic StrokeICAS - Intracranial Atherosclerosis
- First Posted Date
- 2025-03-18
- Last Posted Date
- 2025-03-18
- Lead Sponsor
- Fujian Medical University Union Hospital
- Target Recruit Count
- 250
- Registration Number
- NCT06881420
- Locations
- 🇨🇳
Fujian Medical University Union Hospital, Fuzhou, Fujian, China
Investigation on the Status Quo of Hyperalgesia in Patients After Thoracoscopic Operation and Study on the Effect of Intraoperative Intervention
Not Applicable
Recruiting
- Conditions
- Thoracoscopic SurgeryHyperalgesia
- First Posted Date
- 2025-01-24
- Last Posted Date
- 2025-01-24
- Lead Sponsor
- Fujian Medical University Union Hospital
- Target Recruit Count
- 90
- Registration Number
- NCT06790914
- Locations
- 🇨🇳
Fujian Medical University Union Hospital, Fujian, Fuzhou, China
A Study of RC48-ADC Combined With JS001 for Advanced Extramammary Paget Disease of the Scrotum
Phase 2
Recruiting
- Conditions
- Paget Disease, ExtramammaryScrotum Disease
- Interventions
- Drug: Disitamab Vedotin combined with Toripalimab
- First Posted Date
- 2025-01-24
- Last Posted Date
- 2025-01-24
- Lead Sponsor
- Fujian Medical University Union Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT06791070
- Locations
- 🇨🇳
Fujian Medical University Union Hospital, Fuzhou, Fujian, China
Efficacy and Safety of Ensartinib in Neoadjuvant Therapy for Stage IIA - IIIB (Operable or Potentially Operable) ALK-Positive Lung Adenocarcinoma ：A Multicenter, Real-World Clinical Study
Phase 4
Not yet recruiting
- Conditions
- ALK-positive Advanced NSCLCALK-positive Non-small Cell Lung Cancer (NSCLC)MPRNeoadjuvant Therapy
- Interventions
- First Posted Date
- 2025-01-21
- Last Posted Date
- 2025-01-21
- Lead Sponsor
- Fujian Medical University Union Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT06785584
- Locations
- 🇨🇳
Fujian Medical University Union Hospital, Fuzhou, Fujian, China
Tumor Regression Grade As Predictor of Adjuvant Therapy
Recruiting
- Conditions
- Esophageal Squamous Cell Carcinoma (ESCC)
- Interventions
- Drug: Chemotherapy
- First Posted Date
- 2024-11-28
- Last Posted Date
- 2024-11-28
- Lead Sponsor
- Fujian Medical University Union Hospital
- Target Recruit Count
- 400
- Registration Number
- NCT06710665
- Locations
- 🇨🇳
Fujian Medical University Union Hospital, Fuzhou, Fujian, China